Understanding the Cardiometabolic Patient Journey

This white paper discusses the complexities of the cardiometabolic patient journey, emphasizing the need for life sciences organizations to analyze and quantify these pathways for effective intervention strategies. It outlines the intricacies of managing cardiometabolic diseases, which often involve multiple interconnected conditions such as diabetes, obesity, and atherosclerotic cardiovascular disease (ASCVD). The paper presents a framework for developing patient journey archetypes that can help in identifying and addressing gaps in care. It details the phases of the patient journey, including diagnosis, referrals, treatment initiation, and ongoing management, highlighting the importance of a multidisciplinary approach to care. The insights gained from understanding these journeys are crucial for stakeholders in the pharmaceutical industry, as they inform strategic decision-making and enhance patient-centered healthcare solutions. The methodology section describes the use of secondary data and deep learning models to create scalable archetypes that can be adapted for various patient populations.